Reply to M.J. Brenner et al and I.R. Vogelius et al

Journal of Clinical Oncology

Volumn 32, Issue 17, 2014, Pages 1853-1854

  Pollack, Alan ^a   Walker, Gail ^a   Horwitz, Eric M ^b   Price, Robert ^b   Feigenberg, Steven ^c   Konski, Andre A ^d   Stoyanova, Radka ^a   Movsas, Benjamin ^e   Greenberg, Richard E ^b   Uzzo, Robert G ^b   Ma, Charlie ^b   Buyyounouski, Mark K ^f  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e HENRY FORD HOSPITAL   (United States)

^f STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; CANCER PROGNOSIS; COMPUTER ASSISTED RADIOTHERAPY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LETTER; META ANALYSIS (TOPIC); MODERATE HYPOFRACTIONATION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); UTERINE CERVIX CANCER;

HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84905816268     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.54.7729     Document Type: Letter

References (10)

1. Brenner MJ, Kaplan ID: Is there any benefit from hypofractionation in external-beam irradiation for prostate cancer? J Clin Oncol 32:1851-1852, 2014
2. Vogelius IR, Bentzen SM: Hypofractionated radiation therapy for prostate cancer: More food for thought from recent trial. J Clin Oncol 32:1852-1853, 2014
3. Pollack A, Walker G, Horwitz EM, et al: Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol 31:3860-3868, 2013
4. King CR, Collins S, Fuller D, et al: Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: Results from a multi-institutional consortium of prospective trials. Int J Radiat Oncol Biol Phys 87:939-945, 2013
5. Gardner BG, Zietman AL, Shipley WU, et al: Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer. J Urol 167:123-126, 2002 (Pubitemid 34024514)
6. Eifel PJ, Levenback C, Wharton JT, et al: Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32:1289-1300, 1995
7. Vogelius IR, Bentzen SM: Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: Bad news, good news, or no news? Int J Radiat Oncol Biol Phys 85:89-94, 2013
8. Strigari L, Benassi M, Arcangeli G: In regard to Vogelius and Bentzen. Int J Radiat Oncol Biol Phys 85:897-898, 2013
9. Valdagni R, Nahum AE, Magnani T, et al: Long-term biochemical control of prostate cancer after standard or hyper-fractionation: Evidence for different outcomes between low-intermediate and high risk patients. Radiother Oncol 101:454-459, 2011
10. Arcangeli S, Strigari L, Gomellini S, et al: Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 84:1172-1178, 2012